Literature DB >> 15654828

Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome.

J Y Park1, A Shcherbina, F S Rosen, A P Prodeus, E Remold-O'Donnell.   

Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency/platelet disease due to mutations of WASP, a cytoskeletal regulatory protein of blood cells. Patients exhibit a range of immune defects generally attributed to defective T-cell function, including poor response to immunization, skewed immunoglobulin isotypes, eczema, recurrent infections, autoimmune disease and increased frequency of malignancies. Here we show a deficit of total B-cells in WAS patients of various ages and identify phenotypic perturbations involving complement receptors and CD27. Whereas B-cells of normal healthy donors are overwhelmingly CD21/CD35-positive, B-cells expressing these receptors are significantly reduced in number in WAS patients, and their paucity may cause suboptimal antigen capture and presentation. The frequencies of IgD(-) and IgG(+) patient B-cells were not different from healthy donors (although absolute numbers were decreased), indicating that isotype switching is occurring. In contrast, the frequency of cells positive for CD27, the marker of post germinal centre B-cells, was significantly decreased even among isotype-switched cells, and B-cells resembling germinal centre progenitors (CD10(+)CD27(-)CD38(bright)) were more frequent in adult patients, suggesting impaired germinal centre maturation/differentiation. The documentation of these phenotypic perturbations and deficit of total cells suggest that defects intrinsic to B-cells contribute to the impaired humoral immunity that characterizes this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654828      PMCID: PMC1809280          DOI: 10.1111/j.1365-2249.2005.02693.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

Review 1.  Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.

Authors:  D T Fearon; M C Carroll
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  CD27: a memory B-cell marker.

Authors:  K Agematsu; S Hokibara; H Nagumo; A Komiyama
Journal:  Immunol Today       Date:  2000-05

3.  The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression.

Authors:  Francisco Medina; Carmen Segundo; Antonio Campos-Caro; Inés González-García; José A Brieva
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

4.  WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.

Authors:  A Shcherbina; F S Rosen; E Remold-O'Donnell
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets.

Authors:  H D Ochs; S J Slichter; L A Harker; W E Von Behrens; R A Clark; R J Wedgwood
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

6.  Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.

Authors:  J Ø Bohnhorst; M B Bjørgan; J E Thoen; J B Natvig; K M Thompson
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

7.  Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes.

Authors:  L Westerberg; G Greicius; S B Snapper; P Aspenström; E Severinson
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

8.  HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.

Authors:  S Moir; A Malaspina; K M Ogwaro; E T Donoghue; C W Hallahan; L A Ehler; S Liu; J Adelsberger; R Lapointe; P Hwu; M Baseler; J M Orenstein; T W Chun; J A Mican; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

9.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

10.  Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.

Authors:  J Zhang; A Shehabeldin; L A da Cruz; J Butler; A K Somani; M McGavin; I Kozieradzki; A O dos Santos; A Nagy; S Grinstein; J M Penninger; K A Siminovitch
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Wiskott-Aldrich syndrome: another piece in the puzzle.

Authors:  L D Notarangelo; L Mori
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

2.  WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.

Authors:  Lisa S Westerberg; Miguel A de la Fuente; Fredrik Wermeling; Hans D Ochs; Mikael C I Karlsson; Scott B Snapper; Luigi D Notarangelo
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

Review 3.  The actin-bundling protein L-plastin supports T-cell motility and activation.

Authors:  Sharon Celeste Morley
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

4.  Molecular and phenotypic abnormalities of B lymphocytes in patients with Wiskott-Aldrich syndrome.

Authors:  Karen L Simon; Stacie M Anderson; Elizabeth K Garabedian; Daniele Moratto; Robert A Sokolic; Fabio Candotti
Journal:  J Allergy Clin Immunol       Date:  2013-11-08       Impact factor: 10.793

5.  Intrinsic T- and B-cell defects impair T-cell-dependent antibody responses in mice lacking the actin-bundling protein L-plastin.

Authors:  Elizabeth M Todd; Lauren E Deady; Sharon Celeste Morley
Journal:  Eur J Immunol       Date:  2013-05-18       Impact factor: 5.532

Review 6.  Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.

Authors:  Hans D Ochs
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

7.  Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.

Authors:  Aisha Vanessa Sauer; Immacolata Brigida; Nicola Carriglio; Alessandro Aiuti
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

8.  Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination.

Authors:  Duane R Wesemann; Jennifer M Magee; Cristian Boboila; Dinis Pedro Calado; Michael P Gallagher; Andrew J Portuguese; John P Manis; Xiaolong Zhou; Mike Recher; Klaus Rajewsky; Luigi D Notarangelo; Frederick W Alt
Journal:  J Exp Med       Date:  2011-12-05       Impact factor: 14.307

9.  Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma.

Authors:  Marco Catucci; Maria Carmina Castiello; Francesca Pala; Marita Bosticardo; Anna Villa
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

Review 10.  Wiskott-Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation.

Authors:  Gerben Bouma; Siobhan O Burns; Adrian J Thrasher
Journal:  Immunobiology       Date:  2009-07-22       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.